Abstract
To investigate bronchopulmonary dysplasia (BPD) and its treatment with dexamethasone (DEX) in premature infants with birth weight (BW) P P = 0.004) and neonatal respiratory distress syndrome (OR: 6.146, P = 0.043) were independent risk factors for BPD. DEX was administered to 26 patients after the diagnosis of BPD. After one and two weeks of DEX treatment, the oxygen requirement had significantly reduced compared to the week prior to treatment (P P < 0.001). These results suggest that low GA was the most important risk factor for BPD, DEX reduced oxygen dependency but decreased weight gain.
Highlights
With improvements in neonatal emergency care, preterm infants, very low birth weight (VLBW) infants (
These results suggest that low Gestational age (GA) was the most important risk factor for bronchopulmonary dysplasia (BPD), DEX reduced oxygen dependency but decreased weight gain
Specific treatment methods are lacking, and research into the prevention and amelioration of BPD is urgently required [1]. This retrospective study assessed the prevalence of BPD in VLBW infants over the last 3 years, analyzed the risk factors and clinical features associated with BPD, and determined the short-term efficacy and safety of dexamethasone (DEX) treatment
Summary
With improvements in neonatal emergency care, preterm infants, very low birth weight (VLBW) infants (
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
